Skip to content

MB-EAT rescue test for health education group

A clinical trial of remote mindfulness dietary meditation training (MB-EAT) in obese patients (randomized controlled trial of the efficacy of the MB-EAT group as a control against the health education group) (G2019022) (ongoing) ) Effect study of rescue treatment on health education group

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1033210709
Enrollment
10
Registered
2022-03-30
Start date
2022-03-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Sponsors

Ono Hiraku
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Primary diagnosis of Obesity with a BMI of 30 or higher . 2)The age between 18 to 65. 3)Patients with full consent of participation in the study. 4)Possible to communicate in Japanese. 5)Patients who have an internet environment at home and have a personal computer or tablet device. 6)No addition of weight loss drug or appetite suppressant during the study. 7)Possible to understand Mindfulness-Based Eating Awareness Training and have mental and physical. 8)If Ovesity is primary diagnosed, patients with Depressive Disorder and Anxiety Disorder will not be excluded from the study. 9)Patients who agree not to use weight loss drugs (Sanorex) or Diabetes drug (Ozempic) for about 6 months until the end of the study. 10)Patients who agree not to undergo Bariatric surgery for about 6 months until the end of the study. 11)Those who consent to contraception with their partner while undergoing mindfulness dietary meditation training for safety for approximately 6 months until the end of this study.

Exclusion criteria

Exclusion criteria: 1)Pregnant,lactating or less than 6 months after giving birth. 2)Patients who taking weight loss drugs or Diabetes drug (Ozempic) . 3)Patinets who plan undergo Bariatric surgery. 4)Patients who have Organic brain disorder ( including Dementia), Psychosis, Substance abuse or dependence, other severemental disorders. 5)Active suicidality. 6)Repetitive anti-social behavior. 7)Severe physical condition. 8)Those who have mental retardation (refer to the evaluation scores such as JART-25: Japanese Adult Reading Test-25) and those who have autism spectrum disorder (AQ: refer to the autism spectrum index etc.). 9)Patients who cannot contact with the study organizer. 10)Other relevant reason decided by the investigator.

Design outcomes

Primary

MeasureTime frame
Mean Change from Baseline of Hunger Score in TFEQ subscale( Time Frame: Baseline, 7 weeks from baseline, 14visits and after 6 months (Self-Reported Questionnaire)

Secondary

MeasureTime frame
Mean Change from baseline, 7 weeks from baseline, 14 visits, and after 6 months (1)Body Mass Index (2)Weight loss rate (3)Three-Factor Eating Questionnaire(Total Score, Disinhibition subscale, Cognitive Restraint subscale) (4)Beck Depression Inventory (5)State-Trait Anxiety Inventory (6)Rosenberg Self-Esteem Scale (7)Barratt Impulsiveness Scale (8)Positive and Negative Affect Schedule (9)Binge Eating Scale (10)Five Facet Mindfulness Quesionnaire (11)Mindfulness Attention Awareness Scale (12)Self-Cojmpassion Scale (13)Exercise frequency(Meditation, Yoga, Number of steps) (14)Drug name of concomitant drug and daily dose Presence or absence of adverse events

Contacts

Public ContactJunko Matsumoto

Chiba University

matsujun@chiba-u.jp+81-43-226-2975

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026